Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers.

BMC Cancer · 2025 · PMC11905517 · PMID 40082760

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

However, the positive lymph node involvement was more frequent in the Unclassified subtype, although the difference did not reach statistical significance (66.67%, p = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.